In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype

Clinical and Experimental Immunology

Volumn 148, Issue 3, 2007, Pages 564-572

  Legitimo, A ^a   Consolini, R ^a   Failli, A ^a   Fabiano, S ^a   Bencivelli, W ^a   Scatena, F ^b   Mosca, F ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Dendritic cells; Photopheresis; Psoralen; UVA light

Indexed keywords

METHOXSALEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL KILLING; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PUVA; ULTRAVIOLET A RADIATION;

APOPTOSIS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; METHOXSALEN; MONOCYTES; PHAGOCYTOSIS; PHOTOPHERESIS; PHOTOSENSITIZING AGENTS; ULTRAVIOLET RAYS;

EID: 34247853268     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03372.x     Document Type: Article

References (43)

1. Ardavin C, Amigorena S, Reis e Sousa C. Dendritic cells: immunobiology and cancer immunotherapy. Immunity 2004 20:17 23.
2. Usharauli D. Dendritic cells and the immunity/tolerance decision. Med Hypoth 2005 64:112 13.
3. Xiao BG, Huang YM, Link H. Dendritic cell vaccine design: strategies for eliciting peripheral tolerance as therapy of autoimmune diseases. Biodrugs 2003 17:103 11.
4. Schlichting CL, Schareck WD, Nickel T, Weis M. Dendritic cells as pharmacological targets for the generation of regulatory immunosuppressive effectors. New implications for allo-transplantation. Curr Med Chem 2005 12:1921 30.
5. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001 193:233 8.
6. Kishimoto H, Sprent J. Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of T-cells. J Immunol 1999 163:1817 26.
7. Dhodapkar MV, Steinman RM. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 2002 100:174 7.
8. Spisek R, Gasova Z, Bartunkova J. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion 2006 46:55 65.
9. Watanabe S, Kagamu H, Yoshizawa H et al. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity. J Immunol 2003 171:5828 36.
10. Coates PT, Colvin BL, Hackstein H, Thomson AW. Manipulation of dendritic cells as an approach to improved outcomes in transplantation. Exp Rev Mol Med 2002 18:1 21.
11. Edelson RL. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Ann NY Acad Sci 2001 941:1 11.
12. Girardi M, Berger CL, Wilson LD et al. Transimmunization for cutaneous T cell lymphoma: a phase I study. Leuk Lymph 2006 47:1495 503.
13. Plumas J, Manches O, Chaperot L. Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD. involvement of dendritic cells. Leukemia 2003 17:2061 2.
14. McKenna KE, Whittaker S, Rhodes LE et al., British Photodermatology Group & UK Skin Lymphoma Group. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the UK Skin Lymphoma Group. Br J Dermatol 2006 154:7 20.
15. Heshmati F, Andreu G. for the French Group of Extracorporeal Photochemotherapy. Extracorporeal photochemotherapy: a historical perspective. Tranfus Apher Sci 2003 28:25 34.
16. Duvic M, Chiao N, Talpur R. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Cutan Med Surg 2003 7:3 7.
17. Duvic M. Photopheresis versus transimmunization? Leuk Lymph 2006 47:1449.
18. Edelson RL. Transimmunization: the science catches up to the clinical success. Transfus Apher Sci 2002 26:177 80.
19. Greinix HT, Socie G, Bacigalupo A et al. Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant 2006 38:265 73.
20. Rubegni P, Cuccia A, Sbano P et al. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease. Br J Haematol 2005 130:271 5.
21. Dall'Amico R, Murer L. Extracorporeal photochemotherapy: a new therapeutic approach for allograft rejection. Tranfus Apher Sci 2002 26:197 204.
22. Marshall SR. Technology insight: ECP for the treatment of GVHD - can we offer selective immune control without generalized immunosuppression? Nat Clin Pract Oncol 2006 3:302 14.
23. Urbani L, Mazzoni A, Catalano G et al. The use of extracorporeal photopheresis for allograft rejection in liver transplant patients. Transplant Proc 2004 36:3068 70.
24. Kumlien G, Genberg H, Shanwell A, Tyden G. Photopheresis for the treatment of refractory renal graft rejection. Transplantation 2005 79:123 5.
25. Legitimo A, Consolini R, Di Stefano R, Bencivelli W, Mosca F. Psoralen and UVA light: an in vitro investigation of multiple immunological mechanisms underlying the immunosuppression induction in allograft rejection. Blood Cells Mol Dis 2002 29:24 34.
26. Knobler RM, French LE, Kim Y et al. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 2006 54:793 9.
27. Martelli AM, Cappellini A, Tazzari PL et al. Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes. Haematologica 2004 89:471 9.
28. Bladon J, Taylor PC. Extracorporeal photochemotherapy induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol 1999 107:707 11.
29. Wolnicka-Glubisz A, Rijnkels JM, Sarna T, Beijersbergen vanHenegouwen GM. Apoptosis in leukocytes induced by UVA in the presence of 8-methoxypsoralen, chlorpromazine or 4,6,4′-trimethylangelicin. J Photochem Photobiol B 2002 68:65 72.
30. Yoo EK, Rook AH, Elenitsas R, Gasparro FP, Vowels BR. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996 107:235 42.
31. Legitimo A, Consolini R, Di Stefano R, Bencivelli W, Calleri A, Mosca F. Evaluation of the immunomodulatory effects of photochemotherapy in transplantation. Transplant Proc 2001 33:2266 8.
32. Bladon J, Taylor PC. Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes. Br J Dermatol 2002 146:59 68.
33. Bladon J, Taylor PC. Treatment of cutaneous T cell lymphoma with extracorporeal photopheresis induces Fas-ligand expression on treated T cells, but does not suppress the expression of co-stimulatory molecules on monocytes. J Photochem Photobiol B 2003 69:129 38.
34. Bladon J, Taylor PC. Extracorporeal photopheresis differentially regulates the expression of phosphorylated STAT-1 and STAT-5 in treated monocytes and T cells, respectively. J Cutan Med Surg 2004 8:148 56.
35. Craciun LI, Stordeur P, Schandene L et al. Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease. Transplantation 2002 74:995 1000.
36. Bladon J, Taylor PC. Lymphocytes treated by extracorporeal photopheresis can down-regulate cytokine production in untreated monocytes. Photodermatol Photoimmunol Photomed 2005 21:293 302.
37. Vowels BR, Cassin M, Boufal MH, Walsh LJ, Rook AH. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 1992 98:686 92.
38. Heshmati F. Mechanisms of action of extracorporeal photochemotherapy. Tranfus Apher Sci 2003 29:61 70.
39. Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus host disease. Blood 2002 100:941 7.
40. Maeda A, Shwarz A, Kernebeck K et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005 174:5968 76.
41. Peritt D. Potential mechanisms of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006 12:7 12.
42. Sabelin K, Shulzki A, Kloetzel PM, Dörken B, Pezzuto A, Subklewe M. Impairment of circulating myeloid dendritic cells in immunosuppressed renal/pancreas transplant recipients. Transplantation 2006 82:779 87.
43. Piemonti L, Monti P, Allavena P, Leone BE, Caputo A, Di Carlo V. Glucocorticoids increase the endocytic activity of human dendritic cells. Int Immunol 1999 11:1519 26.